235 related articles for article (PubMed ID: 23297383)
1. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response.
Kwuan L; Adams W; Auerbuch V
Infect Immun; 2013 Mar; 81(3):905-14. PubMed ID: 23297383
[TBL] [Abstract][Full Text] [Related]
2. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
Auerbuch V; Golenbock DT; Isberg RR
PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
[TBL] [Abstract][Full Text] [Related]
4. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
Adams W; Morgan J; Kwuan L; Auerbuch V
Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
[TBL] [Abstract][Full Text] [Related]
5. Type III secretion translocon assemblies that attenuate Yersinia virulence.
Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
[TBL] [Abstract][Full Text] [Related]
6. Macrophage innate immune responses delineate between defective translocon assemblies produced by
Farag SI; Francis MK; Gurung JM; Wai SN; Stenlund H; Francis MS; Nadeem A
Virulence; 2023 Dec; 14(1):2249790. PubMed ID: 37621095
[TBL] [Abstract][Full Text] [Related]
7. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
[TBL] [Abstract][Full Text] [Related]
8. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
Francis MS; Wolf-Watz H
Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
[TBL] [Abstract][Full Text] [Related]
9. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
Sheahan KL; Isberg RR
mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
[TBL] [Abstract][Full Text] [Related]
10.
Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
[TBL] [Abstract][Full Text] [Related]
11. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense.
Zheng Y; Lilo S; Mena P; Bliska JB
PLoS One; 2012; 7(4):e36019. PubMed ID: 22563435
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
Viboud GI; So SS; Ryndak MB; Bliska JB
Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
[TBL] [Abstract][Full Text] [Related]
13. Coiled-coils in the YopD translocator family: a predicted structure unique to the YopD N-terminus contributes to full virulence of Yersinia pseudotuberculosis.
Costa TR; Amer AA; Fällman M; Fahlgren A; Francis MS
Infect Genet Evol; 2012 Dec; 12(8):1729-42. PubMed ID: 22910185
[TBL] [Abstract][Full Text] [Related]
14. Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein.
Ryndak MB; Chung H; London E; Bliska JB
Infect Immun; 2005 Apr; 73(4):2433-43. PubMed ID: 15784589
[TBL] [Abstract][Full Text] [Related]
15. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages.
Zheng Y; Lilo S; Brodsky IE; Zhang Y; Medzhitov R; Marcu KB; Bliska JB
PLoS Pathog; 2011 Apr; 7(4):e1002026. PubMed ID: 21533069
[TBL] [Abstract][Full Text] [Related]
16. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
Edqvist PJ; Aili M; Liu J; Francis MS
Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
[TBL] [Abstract][Full Text] [Related]
17. Random mutagenesis identifies a C-terminal region of YopD important for Yersinia type III secretion function.
Solomon R; Zhang W; McCrann G; Bliska JB; Viboud GI
PLoS One; 2015; 10(3):e0120471. PubMed ID: 25807250
[TBL] [Abstract][Full Text] [Related]
18. Impact of the N-terminal secretor domain on YopD translocator function in Yersinia pseudotuberculosis type III secretion.
Amer AA; Åhlund MK; Bröms JE; Forsberg Å; Francis MS
J Bacteriol; 2011 Dec; 193(23):6683-700. PubMed ID: 21965570
[TBL] [Abstract][Full Text] [Related]
19. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
Harmon DE; Murphy JL; Davis AJ; Mecsas J
J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.
Marenne MN; Journet L; Mota LJ; Cornelis GR
Microb Pathog; 2003 Dec; 35(6):243-58. PubMed ID: 14580388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
